Although the exact mechanisms are not known, it is most likely that the growth factors induce the expansion of CD133+ BTSCs or de-differentiation of glioblastoma cells to CD133+ BTSCs in culture (Kondo, 2007). The gene discussed is PROM1; the disease is glioblastoma.